From the Supplement Skeptic desk · our own calculator
NMN/NAD+ Dosage Crisis: The Buyer's Debugger
1000mg vs 250mg: which NMN dose actually works? Evidence-based calculator with cost-per-benefit.
The most robust human trial (2026) showed that 1,000 mg of NMN daily for 14 days doubled circulating NAD+ levels, while 250 mg is below the studied range and lacks direct evidence of efficacy. This calculator helps you match your age, fitness goal, and budget to the actual research—NMN vs. NR bioavailability, cost-per-study, and whether the bottle in your hand is even dosed like the trials.
- ~1000mg
- NMN dose that doubled NAD+ in 2026 trial
- ≈2x
- NAD+ elevation in 14 days at studied dose
- 250mg
- Common underdosed retail offering
- $0
- Affiliate commission — we cite no brand
- Match your age and longevity goal to the studied dose and expected NAD+ lift
- Compare NMN vs. NR via the evidence—bioavailability, cost-per-doubled-NAD+, and research timeline
- Spot under-dosed retail bottles (and see what the label should say)
- Calculate your actual cost-per-milligram-per-study vs. trendy brands
- Get a plain-English 'is this worth my money?' verdict for your demographic
Free 60-second audit
What's your NMN situation?
Answer 3 questions. We'll show you the studied dose for your demographic and whether your current bottle (or the one you're about to buy) matches the research.
-
1 Why are you considering NMN/NAD+ supplements?
-
2 What dose does your label claim (or are you considering)?
-
3 How long are you willing to try it?
-
Your result
Here's what the evidence predicts for you
Get the calculator — $17 →Based on the 2026 clinical trial, the studied dose that doubled NAD+ levels was ~1000 mg daily for 14 days. If your label shows significantly less (like 250 mg), you're likely underdosed relative to the research. The full NMN/NAD+ Dosage Debugger calculator lets you input your age, goal, budget, and supplement form to see the cost-per-benefit, bioavailability comparison (NMN vs. NR), and whether the hype matches the science.
The short version
NMN and NAD+ supplements are riding a longevity hype wave, but most retail bottles don’t match the doses that were actually studied in humans. A 2026 trial showed that 1,000 mg of NMN daily doubled blood NAD+ levels in healthy adults over 14 days. Many commercial products sell you 250–500 mg per serving—below the studied threshold—at premium prices.
This debugger exists so you can see the gap between the hype and the research, calculate what you’re actually paying per milligram of studied dose, and decide whether it’s worth your money.
How the category tricks you
- The unstudied dose. Retail offerings of 250 mg, 500 mg, or proprietary blends lack direct human efficacy data. Longevity sellers rely on you not knowing what dose was actually studied.
- The form confusion. NMN, NR (nicotinamide riboside), NAM (nicotinamide), and resveratrol all claim to “boost NAD+,” but their bioavailability and evidence bases differ. Buyers often pay premium for NMN without knowing NR has 40+ human trials vs. NMN’s ~15.
- The brand premium. Trendy longevity brands charge $1.50–$3.00 per 100 mg. Generic versions cost $0.50–$1.00. The molecule is the same; the markup is marketing.
- The “doubled NAD+” claim. True from the 2026 trial at 1,000 mg—but ads often omit “over 14 days” and “in healthy adults,” implying instant results for everyone.
- The stacking trap. Sellers mix NMN with resveratrol, PQQ, or CoQ10 at underdosed amounts, creating a “synergy” story instead of studied efficacy.
The debugger turns each of these into a 90-second check: input your demographics, see the studied dose for your age/goal, compare cost-per-study, and spot the under-dosed bottles before you buy.
Who this is for
People considering NMN or other NAD+ precursors who want straight answers: What dose actually works? Is it worth my money? Will a $15/month bottle do anything, or do I need $60/month to match the trial? People already taking NMN who suspect their bottle is under-dosed—this calculator shows you what to look for on the next label.
This is consumer education, not medical advice. NAD+ supplementation, especially at high doses, carries real risks for specific populations (e.g., certain cancers, neurological conditions). Review any NAD+ protocol with a licensed clinician before starting.
The evidence at a glance
Dose that worked in the 2026 trial:
- 1,000 mg NMN daily × 14 days → ~2× increase in circulating NAD+.
- 1,200 mg/day (600 mg × 2) → suppressed exercise-induced inflammatory markers (TNF-α, IL-10).
- 2,000 mg/day (hospitalized COVID-19 patients) → significant NAD+ elevation; safe but specialized context.
Form comparison (evidence & bioavailability):
- NR (nicotinamide riboside, e.g., Niagen): 40+ human trials, 25% more efficient than NMN at raising NAD+ in two head-to-head studies. Lower cost per study.
- NMN: ~15 human trials, emerging evidence, requires conversion before cell entry (slightly lower bioavailability than NR) but may have a direct transporter (SLC12A8) in some tissues.
- NAM (nicotinamide): Cheapest; mixed evidence; less studied for longevity claims.
- Resveratrol: Often stacked with NMN; different pathway (sirtuin activation); lacks direct NAD+ synergy evidence.
Cost-per-benefit reality:
- 1,000 mg NMN at $1.50/100 mg = $15/month; studies support it.
- 250 mg NMN at $30–50/month = $120–200 per 1,000 mg equivalent; no direct human efficacy data at this dose.
The debugger helps you avoid the second scenario.
This is consumer education, not medical advice. Consult a healthcare provider before starting high-dose NAD+ supplementation.
What's inside
- Interactive calculator PDF + spreadsheet — input age, goal, budget, and form preference
- The Dose Audit Table — 250mg vs. 500mg vs. 1000mg + what each was (or wasn't) studied for
- The Form Comparison — NMN vs. NR vs. NAM vs. resveratrol, ranked by bioavailability and evidence count
- The Cost-Per-Benefit Matrix — which brands match the studied dose, cost-per-100mg, cost per NAD+ doubling
- A YMYL safety checklist — age cutoffs, medication interactions, and when to skip it entirely
Frequently asked
What dose of NMN was actually studied in humans?
The most robust 2026 trial used 1,000 mg daily for 14 days and showed a ~2-fold increase in circulating NAD+ levels. Other trials used 1,200 mg/day (600 mg twice daily) and 2 g/day in hospitalized COVID-19 patients. The bottom line: 250–500 mg (common retail dosing) is below the studied range and lacks direct efficacy data in healthy humans.
Is NMN better than NR (nicotinamide riboside)?
Both are NAD+ precursors, but the evidence differs. NR has ~40+ published human studies and demonstrated 25% greater NAD+ elevation in two trials. NMN has emerging data but fewer long-term human studies. For bioavailability, NR crosses cell membranes more directly; NMN requires conversion. The calculator compares cost-per-study and cost-per-expected NAD+ lift for both.
Do I need 1000 mg or can I get away with less?
The 1,000 mg dose achieved robust NAD+ doubling in 14 days. Doses below 500 mg lack strong human evidence. Age matters too: older adults may need the full studied dose; younger, healthy athletes might use 500–750 mg if budget is tight. The calculator personalizes this based on your demographics and goal.
Will NMN actually make me feel different?
NAD+ elevation is real; noticeable energy or longevity effects are harder to prove in short trials. The 2026 trial measured blood NAD+ (objective), not subjective energy. Some users report improved energy, mental clarity, or recovery; others notice nothing. Realistic expectation: measurable NAD+ rise; subjective effects vary.
What exactly do I get for $17?
An interactive calculator PDF + spreadsheet where you input your age, fitness goal, current budget, and supplement form. It outputs the studied dose for your demographic, cost-per-benefit vs. common brands, a bioavailability comparison table (NMN vs. NR vs. other forms), and a safety checklist. One-time payment, 30-day refund, no subscription.
Get NMN/NAD+ Dosage Crisis: The Buyer's Debugger — $17
Secure checkout · card details stay on this page · 30-day money-back guarantee · instant download.
Sources
- A Current List of Completed NMN Human Trials – Renue By Science — 2026 trials: 1000 mg/day doubled NAD+ in 14 days; 1200 mg/day suppressed exercise inflammation; safety up to 1250 mg/day.
- NMN and NR Outperform NAM at Raising NAD⁺ Levels (2026 Trial) — Randomized, 65 healthy adults, 1000 mg/day × 14 days: ~2-fold NAD+ increase; well-tolerated.
- An Updated Review on the Mechanisms, Pre-Clinical and Clinical Comparisons of NMN and NR – Food Frontiers 2025 — Comprehensive meta-analysis: NR 25% more efficient than NMN; NR has 40+ human trials vs NMN's ~15.
- Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women – NIH — Double-blind, placebo-controlled: 1250 mg/day NMN safe for up to 4 weeks in healthy adults.